Last reviewed · How we verify
NCT03046329
Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans
NA trial testing Carevive CPS in Multiple Myeloma in 90 participants. Completed in 31 January 2017.
31 January 2017
Quick facts
| Lead sponsor | Carevive Systems, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 90 |
| Start date | 1 June 2015 |
| Primary completion | 31 January 2017 |
| Estimated completion | 31 January 2017 |
Drugs / interventions tested
- Carevive CPS
Conditions studied
- Multiple Myeloma — all drugs for Multiple Myeloma →
Sponsor
Carevive Systems, Inc.
Who can join
18 and older, any sex, with Multiple Myeloma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overarching objective of this study is to evaluate the symptom assessment and management behaviors used by multiple myeloma (MM) providers for alignment with evidence-based practices, and to explore changes in these symptom care behaviors from baseline to following use of the Carevive Care Planning System (CPS). The overarching goal of the larger program of research is to evaluate the impact of the platform on symptom assessment and management strategies with individuals receiving treatment for multiple myeloma. The current study is focused on determining feasibility of research methods and effect size finding so as to gather the requisite data needed to design fully powered hypothesis testing studies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03046329
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Carevive CPS
Trials testing the same drug.
- NCT03107156 — Understanding Evidence-Based Practice Patterns in Advanced NSCLC · NA · completed
- NCT03231579 — Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study · completed
- NCT03127332 — Metastatic Breast Cancer Treatment Planning · NA · withdrawn
- NCT03161600 — Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Cont · NA · completed
- NCT03068637 — Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma · NA · completed
Other recruiting trials for Multiple Myeloma
Currently open trials in the same condition.
- NCT07200102 — Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma · Phase 1 · recruiting
- NCT07340853 — CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma · Phase 1 · recruiting
- NCT07454382 — A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma · Phase 2 · recruiting
- NCT07266441 — A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma · Phase 2 · recruiting
- NCT07258511 — A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With · Phase 3 · recruiting
Other Carevive Systems, Inc. trials
Trials by the same sponsor.
- NCT05974150 — Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia · recruiting
- NCT05587972 — Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Mon · NA · active not recruiting
- NCT04772118 — Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management. · NA · completed
- NCT04158726 — Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia · NA · completed
- NCT03107156 — Understanding Evidence-Based Practice Patterns in Advanced NSCLC · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03046329 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Carevive Systems, Inc.
- Last refreshed: 7 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03046329.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing